- Home
- RVTY vs BXP Comparison
RVTY vs BXP Comparison
Compare RVTY & BXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVTY | BXP |
|---|---|---|
| Founded | 1937 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 11.5B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | RVTY | BXP |
|---|---|---|
| Price | $101.01 | $69.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 18 |
| Target Price | ★ $112.92 | $77.78 |
| AVG Volume (30 Days) | ★ 1.7M | 1.3M |
| Earning Date | 10-27-2025 | 10-28-2025 |
| Dividend Yield | 0.28% | ★ 4.04% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.99 | N/A |
| Revenue | $2,813,367,000.00 | ★ $3,425,025,000.00 |
| Revenue This Year | $5.33 | $3.60 |
| Revenue Next Year | $3.07 | $1.60 |
| P/E Ratio | $51.70 | ★ N/A |
| Revenue Growth | ★ 3.37 | 2.42 |
| 52 Week Low | $81.36 | $54.22 |
| 52 Week High | $128.29 | $83.29 |
Technical Indicators
Market Signals| Indicator | RVTY | BXP |
|---|---|---|
| Relative Strength Index (RSI) | 57.32 | 40.64 |
| Support Level | $99.35 | $71.22 |
| Resistance Level | $104.84 | $72.50 |
| Average True Range (ATR) | 3.06 | 1.52 |
| MACD | 0.33 | -0.01 |
| Stochastic Oscillator | 66.03 | 16.88 |
Price Performance
Historical ComparisonAbout RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
About BXP Boston Properties Inc.
BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.